From professional translators, enterprises, web pages and freely available translation repositories.
the safety of trametinib in subjects with predisposing factors for rvo, including uncontrolled glaucoma or ocular hypertension, uncontrolled hypertension, uncontrolled diabetes mellitus, or a history of hyperviscosity or hypercoagulability syndromes, has not been established.
trametinibs sikkerhed hos personer med disponerende faktorer for rvo, herunder ukontrolleret glaukom eller okulær hypertension, ukontrolleret hypertension, ukontrolleret diabetes mellitus eller hyperviskositets- eller hyperkoagulabilitetssyndromer i anamnesen, er ikke klarlagt.
